(Alliance News) - Genetic medicines developer Silence Therapeutics PLC said Wednesday its interim loss remained broadly stable during the "transformational" period in which it signed a - Read More
(Alliance News) - Silence Therapeutics PLC said Monday that it has appointed Jorgen Wittendorff to the new role of head of manufacturing.Wittendorff will be joining the company's senior Read More
(Alliance News) - Silence therapeutics PLC said on Thursday that French investment bank Societe Generale SA has a 5% stake in the company.It was not disclosed how many shares, if any, that Read More
LONDON (Alliance News) - Silence Therapeutics PLC said Monday that Steven Romano has joined as non-executive director, as part of the company's collaboration and equity investment by has USD5 Read More
(Alliance News) - New York-listed Mallinckrodt PLC has invested USD5 million into Silence Therapeutics PLC, the two announced on Thursday, as part of a collaboration worth potentially hundreds of Read More
LONDON (Alliance News) - Silence Therapeutics PLC said Thursday it had reappointed Iain Ross as chair of the genetic medicines firm with immediate effect, alongside the hiring of another - who as Read More
LONDON (Alliance News) - Silence Therapeutics PLC said on Thursday Interim Chief Financial Officer Rob Quinn has been promoted to the role on a permanent basis with immediate effect.He will Read More
LONDON (Alliance News) - Silence Therapeutics PLC on Tuesday reported a number of changes to its board and operational team, including its interim chair.Andy Richards has been serving as a Read More
LONDON (Alliance News) - Silence Therapeutics PLC on Monday said its loss widened considerably in its most recent year after a gain on the disposal of its shares in Arrowhead Pharmaceuticals Inc a Read More
LONDON (Alliance News) - Silence Therapeutics on Tuesday said its SLN124 main candidate drug has been designated as an orphan drug in Europe for the treatment of beta-thalassemia.Shares in Read More
LONDON (Alliance News) - Silence Therapeutics PLC said Wednesday Chief Financial Officer David Ellam has resigned from the serious disease treatment firm with immediate effect.Ellam - CFO - Read More
LONDON (Alliance News) - Silence Therapeutics PLC said Thursday the US Patent Trial & Appeal Board rejected Alnylam Pharmaceutics Inc's petition against newly-issued Silence filed a total Read More
LONDON (Alliance News) - Silence Therapeutics PLC said Wednesday it filed a cross-border interim injunction application to stop Alnylam Pharmaceuticals Inc from commercialising patisiran drug drug Read More
